Skip to main content
Premium Trial:

Request an Annual Quote

Arcensus: Arndt Rolfs, Michael Schlenk

Arndt Rolfs has been appointed as CEO of German direct-to-consumer diagnostic genomic testing company Arcensus. He is succeeding Michael Schlenk, who will remain on the company's supervisory board. Rolfs, who founded Arcensus in December 2020, is the former CEO of Centogene, a post he left abruptly in October 2020. He is also a professor of neuro-regeneration at the University of Rostock in Germany.

The Scan

Sensor to Spot SARS-CoV-2 Exposure

Yale researchers have developed a sensor that gauges SARS-CoV-2 exposure, according to the New Haven Register.

Watching BA.2

A subtype of the Omicron SARS-CoV-2 variant has been found in a number of countries, the Washington Post says.

Vermont Weighs Genetic Discrimination Bill

VT Digger reports Vermont legislators are considering a bill to bar insurer from denying customers coverage based on genetic information.

PNAS Papers on Convergent Pathogen Effectors, Lineage-Related RNA Mutations, Desiccation-Tolerant Grass

In PNAS this week: convergent evolution of pathogen effectors, algorithm to identify cell lineage features, and more.